Neuralink Receives FDA Approval , For In-Human Clinical Trials.
On May 25, Elon Musk's neurotech startup Neuralink
received Food and Drug Administration approval
to conduct its first clinical study on humans.
On May 25, Elon Musk's neurotech startup Neuralink
received Food and Drug Administration approval
to conduct its first clinical study on humans.
NBC reports that Neuralink,
which was co-founded by Musk,
is developing a brain implant called the Link.
The implant, which operated solely on
neural signals, aims to help patients with
severe paralysis control external technologies.
The implant, which operated solely on
neural signals, aims to help patients with
severe paralysis control external technologies.
This is the result of incredible work by
the Neuralink team in close collaboration
with the FDA and represents an important
first step that will one day allow our
technology to help many people, Neuralink, via Twitter.
This is the result of incredible work by
the Neuralink team in close collaboration
with the FDA and represents an important
first step that will one day allow our
technology to help many people, Neuralink, via Twitter.
NBC reports that the extent of
the approval trial remains unknown. .
On Twitter, Neuralink said that
patient recruitment is not open
yet for the upcoming clinical trial.
Neuralink requires patients to undergo an invasive
brain surgery to install the Link, a minuscule
implant connected to a series of neural threads. .
Neuralink requires patients to undergo an invasive
brain surgery to install the Link, a minuscule
implant connected to a series of neural threads. .
NBC reports that the FDA's approval for
in-human study represents a major win for
Neuralink, which has faced a number of setbacks. .
In March, Reuters reports that the FDA rejected
the company's application for human trials, citing
"dozens" of issues that needed to be addressed.
